1. Home
  2. OPK

as of 02-24-2026 4:00pm EST

$1.15
$0.00
0.00%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Founded: 2007 Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 967.3M IPO Year: 2011
Target Price: $2.28 AVG Volume (30 days): 2.7M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.26 EPS Growth: N/A
52 Week Low/High: $1.11 - $2.04 Next Earning Date: 01-01-0001
Revenue: $713,142,000 Revenue Growth: N/A
Revenue Growth (this year): -15.29% Revenue Growth (next year): -2.87%
P/E Ratio: -4.44 Index: N/A
Free Cash Flow: -208499000.0 FCF Growth: N/A

Share on Social Networks: